Lenalidomide in Patients With Chronic Myelomonocytic Leukemia

Clinical trial NCT01368757 · UNKNOWN

Trial details

NCT number: NCT01368757
Sponsor: Arbeitsgemeinschaft medikamentoese Tumortherapie
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Myelomonocytic Leukemia

Start date: 2010-06-01
Primary completion: 2015-05-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.